LANGUAGE：
[Ornithine Aspartate for Injection]
Ornithine Aspartate for Injection is indicated for treatment of patients with high blood ammonia disease caused by acute and chronic liver disease such as cirrhosis, fatty liver, hepatitis, especially for relieving central nervous system symptoms caused by liver disease and hepatic coma.
Category
product
Ornithine Aspartate for Injection is indicated for treatment of patients with high blood ammonia disease caused by acute and chronic liver disease such as cirrhosis, fatty liver, hepatitis, especially for relieving central nervous system symptoms caused by liver disease and hepatic coma.
APPLICATIONS
☆ Acute and chronic viral hepatitis
☆ Severe hepatitis
☆ Liver and gallbladder surgery
☆ Tumor radiotherapy and chemotherapy
☆ Alcoholic liver disease and alcohol poisoning;
☆ Fatty liver;
☆ Drug-induced liver injury
PRODUCT'S FEATURES
☆ The only biochemical type of live-protecting new drug approved by CFDA during 1998-2004
☆ Supported by National Key Drug Innovation Program, National Key Product
☆ The only generic manufacturer of Ornithine Aspartate in China
☆ High safety
☆ A necessary drug for the treatment of hepatic encephalopathy and acute hepatic coma
☆ Preferred liver-protecting drug in liver transplant
☆ Comprehensively resolve chemical and biological liver problems, protect and enhance liver functions
☆ With reliable curative effects
PACKING
2.5g/vial *10 vials/box
0.5g/vial *10 vials/box
Prev:
Prev:
Online Message
Please leave your cell phone, our professional staff will contact you as soon as possible!
